BSE filing, BSE: 544694. Summary written from the filing by ALFA Finder's alert engine.
Accretion Nutraveda Ltd: key numbers
- Share price
- ₹290.00
- Market cap
- ₹210.0 Cr
- Revenue (annual)
- ₹33.60 Cr
- Net profit (annual)
- ₹5.07 Cr
- P/E (TTM)
- 41.4×Sector 46.1×
- Promoter holding
- 73.48%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Nutraveda Ltd
All →Accretion Nutraveda Board Meeting Date
Accretion Nutraveda will hold a board meeting on 31 October 2026 to consider unaudited financial results for the half year ended September 2026. The intimation is a prior notice under Regulation 29.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited announced results of its postal ballot. Shareholders approved special resolutions regarding MOA alteration, borrowing limits, and various loan and guarantee authorizations.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited issued a Notice of Postal Ballot to seek shareholder approval for the alteration of its Memorandum of Association. Voting concludes on October 9, 2026.
Accretion Nutraveda Board Meeting Outcome
Accretion Nutraveda's board approved altering its Object Clause to include nutraceuticals and hospitals. The board also proposed increasing borrowing limits and advancing loans to related entities.
Accretion Nutraveda Annual General Meeting
Accretion Nutraveda Limited held its 5th Annual General Meeting on 27th August, 2026, where shareholders transacted routine business, including the adoption of financial statements.
Accretion Nutraveda Other Announcement
Accretion Nutraveda Limited informed shareholders of the weblink to access the FY 2025-26 Annual Report and notice for the 5th Annual General Meeting.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.